165 related articles for article (PubMed ID: 30660664)
1. Clinical Experience With the Use of Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis.
Karlstedt E; Jimenez-Zepeda V; Howlett JG; White JA; Fine NM
J Card Fail; 2019 Mar; 25(3):147-153. PubMed ID: 30660664
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.
Lohrmann G; Pipilas A; Mussinelli R; Gopal DM; Berk JL; Connors LH; Vellanki N; Hellawell J; Siddiqi OK; Fox J; Maurer MS; Ruberg FL
J Card Fail; 2020 Sep; 26(9):753-759. PubMed ID: 31805416
[TBL] [Abstract][Full Text] [Related]
3. Correct Diagnosis of Wild-Type Transthyretin-Related Amyloidosis Followed by the Introduction of a Novel Therapy in a Patient With Cardiac Wall Thickening of Unknown Cause.
Sawada N; Nakayama A; Takahashi M; Tanaka M; Morita H; Akazawa H; Komuro I
Int Heart J; 2017 Feb; 58(1):147-150. PubMed ID: 28111409
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin cardiac amyloidosis in patients after TAVR: clinical and echocardiographic findings and long term survival.
Shimoni S; Zikri M; Haberman D; Livschitz S; Tshori S; Fabricant Y; Meledin V; Gandelman G; Goland S; George J
ESC Heart Fail; 2021 Dec; 8(6):4549-4561. PubMed ID: 34704399
[TBL] [Abstract][Full Text] [Related]
5. Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value.
Cipriani A; De Michieli L; Porcari A; Licchelli L; Sinigiani G; Tini G; Zampieri M; Sessarego E; Argirò A; Fumagalli C; De Gaspari M; Licordari R; Russo D; Di Bella G; Perfetto F; Autore C; Musumeci B; Canepa M; Merlo M; Sinagra G; Gregori D; Iliceto S; Perazzolo Marra M; Cappelli F; Rapezzi C
JACC CardioOncol; 2022 Nov; 4(4):458-470. PubMed ID: 36444225
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
Buss SJ; Emami M; Mereles D; Korosoglou G; Kristen AV; Voss A; Schellberg D; Zugck C; Galuschky C; Giannitsis E; Hegenbart U; Ho AD; Katus HA; Schonland SO; Hardt SE
J Am Coll Cardiol; 2012 Sep; 60(12):1067-76. PubMed ID: 22883634
[TBL] [Abstract][Full Text] [Related]
7. Effect of doxycycline and ursodeoxycholic acid on transthyretin amyloidosis.
Wixner J; Pilebro B; Lundgren HE; Olsson M; Anan I
Amyloid; 2017 Mar; 24(sup1):78-79. PubMed ID: 28042702
[No Abstract] [Full Text] [Related]
8. Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience.
Ikram A; Donnelly JP; Sperry BW; Samaras C; Valent J; Hanna M
Amyloid; 2018 Sep; 25(3):197-202. PubMed ID: 30388377
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
10. Impact of tafamidis on myocardial strain in transthyretin amyloid cardiomyopathy.
Rettl R; Duca F; Binder C; Dachs TM; Cherouny B; Camuz Ligios L; Mann C; Schrutka L; Dalos D; Charwat-Resl S; Badr Eslam R; Kastner J; Bonderman D
Amyloid; 2023 Mar; 30(1):127-137. PubMed ID: 36251806
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
12. Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.
Arvidsson S; Pilebro B; Westermark P; Lindqvist P; Suhr OB
PLoS One; 2015; 10(11):e0143456. PubMed ID: 26600306
[TBL] [Abstract][Full Text] [Related]
13. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T;
PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285
[TBL] [Abstract][Full Text] [Related]
14. Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.
Minamisawa M; Claggett B; Adams D; Kristen AV; Merlini G; Slama MS; Dispenzieri A; Shah AM; Falk RH; Karsten V; Sweetser MT; Chen J; Riese R; Vest J; Solomon SD
JAMA Cardiol; 2019 May; 4(5):466-472. PubMed ID: 30878017
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation.
Di Bella G; Minutoli F; Piaggi P; Casale M; Mazzeo A; Zito C; Oreto G; Baldari S; Vita G; Pingitore A; Khandheria BK; Carerj S
Am J Cardiol; 2015 Oct; 116(7):1122-7. PubMed ID: 26253999
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline and Ursodiol for ATTR Amyloidosis: Not Ready for Prime Time.
Witteles RM
J Card Fail; 2019 Mar; 25(3):154-155. PubMed ID: 30726714
[No Abstract] [Full Text] [Related]
17. Cardiac Amyloid Load: A Prognostic and Predictive Biomarker in Patients With Light-Chain Amyloidosis.
Kristen AV; Brokbals E; Aus dem Siepen F; Bauer R; Hein S; Aurich M; Riffel J; Behrens HM; Krüger S; Schirmacher P; Katus HA; Röcken C
J Am Coll Cardiol; 2016 Jul; 68(1):13-24. PubMed ID: 27364045
[TBL] [Abstract][Full Text] [Related]
18. Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
Goland S; Volodarsky I; Fabricant Y; Livschitz S; Tshori S; Cuciuc V; Zilberman L; Fugenfirov I; Meledin V; Shimoni S; Josfberg S; George J
PLoS One; 2021; 16(7):e0254104. PubMed ID: 34242301
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery targeted at transthyretin cardiac amyloidosis: rational design, synthesis, and biological activity of new transthyretin amyloid inhibitors.
Blasi D; Pinto M; Nieto J; Arsequell G; Valencia G; Planas A; Centeno NB; Quintana J
Amyloid; 2011 Jun; 18 Suppl 1():55-7. PubMed ID: 21838431
[No Abstract] [Full Text] [Related]
20. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
